tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market

Hansoh Pharmaceutical Group Company Limited (3692) Financial Statements

Compare
3 Followers

Hansoh Pharmaceutical Group Company Limited Financial Overview

Hansoh Pharmaceutical Group Company Limited's market cap is currently HK$108.74B. The company's EPS TTM is HK$0.861; its P/E ratio is 21.28; and it has a dividend yield of 1.87%. Hansoh Pharmaceutical Group Company Limited is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 10.10B¥ 9.38B¥ 9.94B¥ 8.69B¥ 8.68B
Gross Profit¥ 9.07B¥ 8.51B¥ 9.06B¥ 7.89B¥ 7.95B
Operating Income¥ 2.84B¥ 2.61B¥ 2.82B¥ 2.77B¥ 2.78B
EBITDA¥ 4.20B¥ 2.93B¥ 3.08B¥ 2.99B¥ 2.96B
Net Income¥ 3.28B¥ 2.58B¥ 2.71B¥ 2.57B¥ 2.56B
Balance Sheet
Cash & Short-Term Investments¥ 24.86B¥ 21.63B¥ 18.94B¥ 13.73B¥ 14.60B
Total Assets¥ 33.04B¥ 30.00B¥ 27.16B¥ 20.79B¥ 19.58B
Total Debt¥ 4.30B¥ 4.38B¥ 3.83B¥ 92.75M¥ 9.44M
Net Debt¥ -18.13B¥ -13.24B¥ -10.87B¥ -4.19B¥ -8.23B
Total Liabilities¥ 7.24B¥ 7.35B¥ 7.13B¥ 2.92B¥ 6.53B
Stockholders' Equity¥ 25.79B¥ 22.65B¥ 20.03B¥ 17.88B¥ 13.04B
Cash Flow
Free Cash Flow¥ 2.75B¥ 2.47B¥ 2.12B¥ 962.83M¥ 2.74B
Operating Cash Flow¥ 3.12B¥ 2.74B¥ 2.58B¥ 2.39B¥ 3.33B
Investing Cash Flow¥ 1.07B¥ -5.94B¥ -2.26B¥ -2.87B¥ -7.08B
Financing Cash Flow¥ -753.70M¥ -818.14M¥ 3.42B¥ -1.04B¥ 7.99B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History

Hansoh Pharmaceutical Group Company Limited Debt to Assets

Hansoh Pharmaceutical Group Company Limited Cash Flow

Hansoh Pharmaceutical Group Company Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis